Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

FDA approval of novel Claritin formulation sought

June 21, 1996

Intranasal NPY: Potential allergic rhinitis agent

June 21, 1996

PDE IV inhibitor selected for further study

June 14, 1996

Sankyo reveals PAF antagonists

June 14, 1996

LTB4 antagonists from Pfizer

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Phase III trials on Kyowa Hakko's olopatidine HCl complete

June 7, 1996

SJC13: LPS-stimulated adhesion inhibitor

June 7, 1996

Searle discloses LTA4 hydrolase inhibitors

June 7, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...